• Fluoxetine is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder , and premenstrual dysphoric disorder ( PMDD ). (emedicinehealth.com)
  • For dogs, the dose of fluoxetine is 0.5 to 1 mg per pound (1 to 2 mg/kg) given every 24 hours, orally. (petplace.com)
  • Administer doses above 20 mg/day once daily in the morning or twice daily (i.e., morning and noon).The maximum fluoxetine dose should not exceed 80 mg/day. (rxlist.com)
  • Recently, there have been suggestions that fluoxetine can induce suicidal tendencies in a small number of patients, but more investigations must be conducted to confirm this supposition. (fsu.edu)
  • Our own research group recently completed a first double-blind, placebo-controlled study of fluoxetine in adults with comorbid MDD and alcohol dependence (Cornelius et al. (clinicaltrials.gov)
  • Fluoxetine is a prescription drug and can only be obtained from a veterinarian or by prescription from a veterinarian. (petplace.com)
  • Patients with major depressive disorder will receive 20 mg/day of fluoxetine for six weeks. (bioportfolio.com)
  • We previously reported that morning bright light therapy is efficacious in adults with nonseasonal major depressive disorder (MDD), both on its own and in combination with fluoxetine. (bioportfolio.com)
  • 1997) That study demonstrated efficacy for fluoxetine in non-AUD adolescents with major depressive disorder (MDD). (clinicaltrials.gov)
  • If you have an allergy to fluoxetine or any other part of this drug. (mskcc.org)
  • For example, impairment in spatial working memory and decreased hippocampal neurogenesis is induced in rats by the chemotherapy agent methotrexate, but co-administration of the (FDA-cleared and commercially available) drug fluoxetine has been shown to counteract the negative long-term effects on memory and hippocampal neurogenesis otherwise occurring after methotrexate administration. (knowcancer.com)
  • If use of fluoxetine in cancer patients can be validated in this manner and lead to its adoption in the clinical setting, it will constitute the first drug with demonstrated utility for the prevention of cerebral dysfunction associated with exposure to chemotherapy. (knowcancer.com)
  • Neuropsychologic testing will be conducted in parallel with neuroimaging studies and, as a step towards understanding mechanisms underlying neurotoxic effects of chemotherapy and potentially related to protective effects of fluoxetine, peripheral markers of inflammatory cytokines will be measured in blood samples drawn at the time of neuroimaging (Specific Aim 3). (knowcancer.com)
  • Our own research group also recently completed a pilot study involving open label fluoxetine in adolescents with comorbid AUD and MDD. (clinicaltrials.gov)